123
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, Spectroscopy and in vitro Cytotoxicity of New Hydroxyanthraquinonato Triorganotin CompoundsFootnote

, , &
Pages 41-51 | Received 08 Oct 2006, Accepted 24 Nov 2006, Published online: 30 Mar 2007
 

We will present herein data on the synthesis, structural investigation and in vitro antitumor activity of new triorganotin compounds of the general type (R3Sn)2Q, where R=Bu, Ph, Bz, Q1=1,4‐dihydroxy‐9,10‐anthracenedione (quinizarin), Q2=1,5‐dihydroxy‐9,10‐anthracenedione (anthrarufin), Q3=2,3‐dihydro‐9,10‐dihydroxy‐1,4‐anthracenedione (leucoquinizarin) and R3SnQ 4 where Q4=1,2‐dihydroxy‐9,10‐anthracenedione (alizarin). The compounds were synthesized by refluxing the organotin hydroxide with the parent quinone and were characterized by IR, 1H‐ NMR and thermal measurements. The spectroscopic analysis of the new triorganotins, provides evidence on the formation of a monodentate Sn‐O bond for quinizarin, anthrarufin and leucoquinizarin, which are coordinated to Sn(IV) central atom via the phenolic oxygen donor atoms, with the R‐substituents of the organotin moiety completing the tetrahedral coordination environment. On the contrary, organotin alizarinates form a six‐membered chelate ring, which stabilizes the Sn central atom in a five‐coordinated environment exhibiting distorted trigonal bipyramidal geometry. The ligand is coordinated to Sn (IV) via the quinoidal oxygen and its neighbouring phenolic one. The new compounds were tested for their cytotoxicity against human tumor and normal cell lines and the results are reported.

Notes

We thank Mr. Sidiropoulos and Associate Professor Mrs. Lalia‐Kantouri for acquiring the thermal analysis data and Assistant Professor Mrs. A. Kourounakis for providing the 1H‐NMR spectra.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.